SMTL ID : 7wcl.1 (1 other biounit)

Crystal structure of FGFR1 kinase domain with Pemigatinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x 8ZF: 11-[2,6-bis(fluoranyl)-3,5-dimethoxy-phenyl]-13-ethyl-4-(morpholin-4-ylmethyl)-5,7,11,13-tetrazatricyclo[7.4.0.0^{2,6}]trideca-1(9),2(6),3,7-tetraen-12-one(Non-covalent)

8ZF.1: 19 residues within 4Å: Chain A: K.27, L.29, V.37, A.57, K.59, E.76, M.80, I.90, V.104, V.106, E.107, Y.108, A.109, S.110, G.112, L.175, A.185, D.186, F.187 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.29, A:A.57 Hydrogen bonds: A:Y.108, A:A.109, A:A.109, A:D.186, A:D.186 Water bridges: A:F.187

4 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: R.172, T.202, N.204, R.206 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:T.202, A:T.202, A:N.204 Water bridges: A:N.173 Salt bridges: A:R.172, A:R.206 SO4.3: 7 residues within 4Å: Chain A: R.115, R.206, L.207, K.210, W.211, S.244, P.245 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:L.207, A:S.244 Salt bridges: A:R.115, A:K.210 SO4.4: 4 residues within 4Å: Chain A: R.122, S.129, G.243, S.244 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:S.129, A:S.129, A:S.244 Water bridges: A:Q.119 Salt bridges: A:R.122 SO4.5: 5 residues within 4Å: Chain A: G.32, C.33, G.35, K.59, D.186 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:C.33, A:G.35, A:D.186 Salt bridges: A:K.59

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lin, Q. et al., Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants. Commun Chem (2022)

Release Date

2022-09-14

Peptides

Fibroblast growth factor receptor 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fibroblast growth factor receptor 1

Related Entries With Identical Sequence